Emergent BioSolutions (EBS) Misses Q1 EPS by 25c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.70 +0.35%
Revenue Growth %: -45.6%
Financial Fact:
Interest income: 358K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -45.6%
Financial Fact:
Interest income: 358K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of ($0.03), $0.25 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $117.8 million versus the consensus estimate of $140.42 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- MasterCraft (MCFT) Tops Q4 EPS by 3c, Beats on Revenue; Offers Guidance
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
